Inflammatory bowel disease

Indian Journal of Pediatrics

Volumn 67, Issue 10, 2000, Pages 747-756

  Vohra, Pankaj ^a  

^a Pushpawati Singhania Research Institute   (India)

Author keywords

Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; CEFALEXIN; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN A; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METRONIDAZOLE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE;

ANTIGEN PRESENTING CELL; ARTHROPATHY; CONFERENCE PAPER; CROHN DISEASE; ENTERITIS; GENETIC RISK; GROWTH DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER DISEASE; OSTEOPOROSIS; PATHOGENESIS; ULCERATIVE COLITIS; VEIN THROMBOSIS;

EID: 0033749670     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723935     Document Type: Conference Paper

References (31)

1. Glickman RM. Inflammatory bowel disease. In: Fauci AS ed. Harrison's Principles of Internal Medicine. 14th edn. McGraw-Hill 1998; 1632-1645.
2. Goenka MK, Kochhar R, Mehta SK. Spectrum of lower gastrointestinal hemorrhage: An endoscopic study of 166 patients. Indian J Gastroenterol 1993; 12 : 129-131.
3. Pai CG, Khandige GK. Is Crohn's disease rare in India? Indian J Gastroenterol, 2000; 19 : 17-20.
4. Murch SM. Inflammatory bowel diseasees. In : Michael Gracey and Walker-Smith JA, eds. Diarrheal Diseases. Nestle Nutrition Workshop Series; Vol. 38, Nestle Ltd., Vevey/Lippincort-Raven Publishers; Philadelphia, 1997; 265-275.
5. Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ. Early determinants of inflammatory bowel disease : Use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000; 12 : 25-30.
6. Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS. Passive smoking is associated with an increased risk of developing inflammatory bowel disease. Am J Gastroenterol 1993; 88 : 356-359.
7. Bonapace CR and Mays BA. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease. Ann Pharma 1997; 31 : 907-913.
8. Polito JM, Rees RC, Childs B, Mendeloff AI, Harris ML, Bayless TM. Preliminary evidence for genetic anticipation in Crohn's disease. Lancet 1996; 347 : 798-800.
9. Danze PM, Colombel JF, Jacquot S et al. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 1996; 39 : 69-72.
10. Cho JH, Fu Y, Kirschner BS, Hanauer SB. Confirmation of a susceptibility locus IBD I for Crohn's disease on chromosome 16. Gastroenterology 1997; 12 : A 948.
11. Mayer L, Yio XY, Lin A, Panja A. Pathogenesis of IBD. Mt Sinai J Med 1996; 63 : 202-209.
12. Sartor RB. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994; 106 : 633-539.
13. Ekbom A, Wakefield AJ, Zach M, Adamin HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994; 344 : 508-510.
14. Hyams J, Davis P, Lerer T et al. Clinical outcome of ulcerative proctitis in childhood. J Pediatr Gastroenterol Nutr 1997; 25 : 149-152.
15. Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 1994; 19 : 7-21.
16. Griffiths AM, Zachos M. Antineutrophil cytoplasmic antibodies and anti-Sacchromyces cerevisiae antibody: Clinical tools or clues for research? J Pediatr Gastroenterol Nutr 2000; 30 : 1-2.
17. Haber HP, Busch A, Ziebach R, Stern. Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children. Lancet 2000; 355 : 1239-1240.
18. Ludwig D, Weiner S, Bruning A, Schwarting K, Jantschek G, Strange EF. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease. A prospective followup study. Am J Gastroenterol 1999; 94 : 2942-2950.
19. Cucchiara S, Celentano C, de Magistris T, Montrisci A, Iula VD, Fecarotta S. Colonoscopy and technetium - 99m white cell scan in children with suspected inflammatory bowel disease. J Pediatr 1999; 15 : 727-732.
20. Lofberg R, Danielsson A, Suhr O et al. Oral budenoside versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology 1996; 110 : 1713-1718.
21. Feagan BG, Rochon J, Fedorak RN et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995; 332 : 292-297
22. Vohra P, Burroughs MH, Hodes DS et al. Disseminated nocardiosis complicating medical therapy in Crohn's disease. J Pediatr Gastroenterol Nutr 1997; 25 : 233-235.
23. Dubinsky MC, Lamothe S, Yang HY et al. Pharmacogenomics and metabolite measurement for 6-Mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118 : 706-713.
24. Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330 : 1841-1845.
25. Ramakrishna J, Langhans N, Calenda K, Grand RJ, Verhave M. Combined use of cyclosporine and azathioprine or 6-Mercaptopurine in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1996; 22 : 296-302.
26. Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ. Combination therapy with oral tacrolimus (FK 506) and azathioprine or 6-mercaptopurine for treatment refractory CD perianal fistulae. Inflammatory Bowel Disease 1999; 5 : 239-245.
27. Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes DP, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995; 90 : 220-223.
28. Targan SR, Hanauer SB, van Deventei S et al. Short term study of chimeric, monoclonal antibody CA2 to tumor necrosis factor for Crohn's disease. Crohn's disease CA2 study group. N Engl J Med 1997; 337 : 1029-1035.
29. Fell JM, Paintin M, Arnand-Battandier F et al. Mucosal healing and fall in pro-inflammatory cytokine mRNA induced by a specific oral diet in paediatric Crohn's disease. Aliment Pharmacol Therap 2000; 14 : 281-289.
30. Sarigol S, Caufield M, Wyllie R et al. Heal pouch-anal anastomosis in children with ulcerative colitis. Inflammatory Bowel Disease 1996; 2 : 82-87.
31. Greenstein AJ.Cancer in inflammatory bowel disease. Mt Sinai J Med 2000; 67 : 227-240.